Indirect data suggest oral semaglutide outperforms orforglipron on weight loss and tolerability, with patients also favoring its treatment profile.

Laboratory testing validates low migration, low odor, and low VOC in clean, sustainable secondary packaging. Even paperboard with post-consumer recycled content passed the analytical methodology and ...

Richard Jaenisch and Christopher Cole discuss AI in pharma manufacturing, covering learning steps, output evaluation, hallucinations, and FDA/EMA guiding principles.

Lilly licenses Insilico's AI drug discovery platform in a deal worth up to $2.75B, signaling a shift in how novel ...

This week, PharmTech discussed proactive, data-driven contamination control, solving manufacturing hurdles, and the market entry of complex generics and biosimilars. This week, PharmTech took a look ...

PRAC-triggered post-authorization actions for cenobamate will cascade across SmPC, PIL, and controlled regulatory materials, ...

As a part of PDA Week 2026, Christopher Lewis, Emoja Biopharma and President of the Mountain States PDA Chapter, sat down ...

Legacy web forms used for clinical trial recruitment, adverse event reporting, laboratory data collection, and regulatory ...

EMA states that reduction in animal testing will be gradual. The first qualification opinion for a NAM used in toxicity ...